Md. Rizwanullah
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 18
- Advancements in Transdermal Drug Delivery 14
- Drug Solubulity and Delivery Systems 6
- Biomaterials 24
- Nanoparticle-Based Drug Delivery 23
- Co-authors
- Saima Amin (21 shared papers)Javed Ahmad (20 shared papers)Showkat R. Mir (12 shared papers)Syed Sarim Imam (12 shared papers)Sultan Alshehri (9 shared papers)Mohammad Zaki Ahmad (11 shared papers)Sohail Akhter (6 shared papers)Mohammad Ahmed Khan (4 shared papers)
- Journals
- Journal of Drug Delivery Science and Technology (6 papers)Current Pharmaceutical Design (5 papers)Polymers (3 papers)Artificial Cells Nanomedicine and Biotechnology (2 papers)Pharmaceutics (2 papers)
- Partner nations
- IndiaSaudi ArabiaFrance
In The Last Decade
Md. Rizwanullah
62 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 124
- Pharmaceutical Science 785
- Biomaterials 784
- Molecular Medicine 157
- Complementary and alternative medicine 140
- Toxicology 60
Countries citing papers authored by Md. Rizwanullah
This map shows the geographic impact of Md. Rizwanullah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md. Rizwanullah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md. Rizwanullah more than expected).
Fields of papers citing papers by Md. Rizwanullah
This network shows the impact of papers produced by Md. Rizwanullah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md. Rizwanullah. The network helps show where Md. Rizwanullah may publish in the future.
Co-authors
The 25 scholars most cited alongside Md. Rizwanullah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 199 | |
| 2 | 2015 | 150 | |
| 3 | 2020 | 120 | |
| 4 | 2017 | 110 | |
| 5 | 2020 | 99 | |
| 6 | 2017 | 99 | |
| 7 | 2021 | 90 | |
| 8 | 2017 | 88 | |
| 9 | 2016 | 84 | |
| 10 | 2017 | 78 | |
| 11 | 2016 | 77 | |
| 12 | 2021 | 76 | |
| 13 | 2020 | 72 | |
| 14 | 2019 | 69 | |
| 15 | 2017 | 63 | |
| 16 | 2019 | 60 | |
| 17 | 2020 | 57 | |
| 18 | 2021 | 56 | |
| 19 | 2021 | 46 | |
| 20 | 2020 | 44 |
About Md. Rizwanullah
Md. Rizwanullah is a scholar working on Pharmaceutical Science, Biomaterials, Molecular Biology, Biomedical Engineering and Complementary and alternative medicine, having authored 65 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (23 papers), Advanced Drug Delivery Systems (18 papers), Advancements in Transdermal Drug Delivery (14 papers), Nanoplatforms for cancer theranostics (10 papers), RNA Interference and Gene Delivery (9 papers), Nigella sativa pharmacological applications (7 papers), Drug Solubulity and Delivery Systems (6 papers) and Graphene and Nanomaterials Applications (5 papers). The work is most often cited by research in Pharmaceutical Science (785 citations), Biomaterials (784 citations), Molecular Medicine (157 citations), Complementary and alternative medicine (140 citations) and Toxicology (60 citations). Md. Rizwanullah has collaborated with scholars based in India, Saudi Arabia and France. Frequent co-authors include Saima Amin, Javed Ahmad, Showkat R. Mir, Syed Sarim Imam, Sultan Alshehri, Mohammad Zaki Ahmad, Sohail Akhter, Mohammad Ahmed Khan, Keerti Jain and Vineet Jain. Their work appears in journals such as Journal of Drug Delivery Science and Technology, Current Pharmaceutical Design, Polymers, Artificial Cells Nanomedicine and Biotechnology and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.